Philippe L. Pereira
Research Subjects
Philippe L. Pereira has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
C D Claussen
7 shared publicationsJ Trübenbach
6 shared publicationsC. D. Claussen
Eberhard-Karls-Universität Tübingen
5 shared publicationsClaus D. Claussen
5 shared publicationsDiethard Schmidt
4 shared publicationsC. W. König
3 shared publications
Latest Publications
- Open Access
- 2 April 2009
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 33
Indications for computed tomography (CT-) diagnostics in proximal humeral fractures: a comparative study of plain radiography and computed tomography
Background: Precise indications for computed tomography (CT) in proximal humeral fractures are not established. The purpose of this study was a comparison of conventional radiographic views with different CT reconstructions with 2 D and 3 D imaging to establish indications for additional CT diagnostics depending on the fractured parts. Methods: In a prospective diagnostic study in two level 1 trauma centers, 44 patients with proximal humeral fractures were diagnosed with conventional X-rays (22 AP + axillary views, 22 AP + scapular Y-views) and CT (multi-planar reconstruction (MPR) and maximum intensity projection (MIP)) with 2 D and 3 D imaging. 3 observers assessed the technical image quality, the assessment of the relevant anatomical structures (2-sample-t-test) and the percentage of the osseous overlap of the proximal humerus (Welch-test) using a scoring system. The quality of the different diagnostic methods was assessed according to the number of fractured parts (Bonferroni-Holm adjustment). Results: There was significantly more overlap of the fractured region on the scapular Y-views (mean 71.5%, range 45–90%) than on axillary views (mean 56.2%, range 10.5–100%). CT-diagnostics allowed a significantly better assessment of the relevant structures than conventional diagnostics (p < 0.05) independently of the fracture severity (two-, three-, and four-part fractures). Conclusion: Conventional X-rays with AP view and a high-quality axillary view are useful for primary diagnostics of the fracture and often but not always show a clear presentation of the relevant bony structures such as both tuberosities, the glenoid and humeral head. CT with thin slices technology and additional 3 D imaging provides always a clear presentation of the fractured region. Clinically, a CT should be performed – independently of the number of fractured parts – when the proximal humerus and the shoulder joint are not presented with sufficient X-ray-quality to establish a treatment plan.
- 2 April 2009
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 33
Open AccessIndications for computed tomography (CT-) diagnostics in proximal humeral fractures: a comparative study of plain radiography and computed tomography
Background: Precise indications for computed tomography (CT) in proximal humeral fractures are not established. The purpose of this study was a comparison of conventional radiographic views with different CT reconstructions with 2 D and 3 D imaging to establish indications for additional CT diagnostics depending on the fractured parts. Methods: In a prospective diagnostic study in two level 1 trauma centers, 44 patients with proximal humeral fractures were diagnosed with conventional X-rays (22 AP + axillary views, 22 AP + scapular Y-views) and CT (multi-planar reconstruction (MPR) and maximum intensity projection (MIP)) with 2 D and 3 D imaging. 3 observers assessed the technical image quality, the assessment of the relevant anatomical structures (2-sample-t-test) and the percentage of the osseous overlap of the proximal humerus (Welch-test) using a scoring system. The quality of the different diagnostic methods was assessed according to the number of fractured parts (Bonferroni-Holm adjustment). Results: There was significantly more overlap of the fractured region on the scapular Y-views (mean 71.5%, range 45–90%) than on axillary views (mean 56.2%, range 10.5–100%). CT-diagnostics allowed a significantly better assessment of the relevant structures than conventional diagnostics (p < 0.05) independently of the fracture severity (two-, three-, and four-part fractures). Conclusion: Conventional X-rays with AP view and a high-quality axillary view are useful for primary diagnostics of the fracture and often but not always show a clear presentation of the relevant bony structures such as both tuberosities, the glenoid and humeral head. CT with thin slices technology and additional 3 D imaging provides always a clear presentation of the fractured region. Clinically, a CT should be performed – independently of the number of fractured parts – when the proximal humerus and the shoulder joint are not presented with sufficient X-ray-quality to establish a treatment plan.
- 26 February 2009
- Published by SPIE-Intl Soc Optical Eng
- Vol. 7261, 72610F
Fast registration of pre- and peri-interventional CT images for targeting support in radiofrequency ablation of hepatic tumors
Radiofrequency (RF) ablation is an image-guided minimally invasive therapy which destroys a tumor by locally inducing electrical energy into the malignant tissue through a radiofrequency applicator. Treatment success is essentially dependent on the accurate placement of the RF applicator. In the case of CT-guided RF ablation of liver tumors, a central problem during monitoring is the reduced quality and information content in the peri-interventional images compared to the images used for planning. Therefore, the question of how to effectively transfer information from the planning scan into the peri-interventional scan in order to support the interventionalist is of high interest. Key to such an enhancement of peri-interventional scans is an adequate registration of the pre- and peri-interventional image, which also needs to be fast since intervention duration is still a challenge. We present an approach for the fast and automatic registration of a high quality CT volume scan of the liver to a spiral CT scan of lower quality. Our method combines an approximate pre-registration to compensate large displacements and a rigid registration of a liver subvolume for further refinement. The method focuses on the position of the tumor to be ablated and the corresponding access path. Thereby, it achieves both fast and precise results in the region of interest. A preliminary evaluation, on 37 data sets from 20 different patients, shows that the registration is performed within a maximum of 18 seconds, while obtaining high accuracy in the relevant region of the liver comprising tumor and the planned access path.
- 26 February 2009
- Published by SPIE-Intl Soc Optical Eng
- Vol. 7261, 72610F
Fast registration of pre- and peri-interventional CT images for targeting support in radiofrequency ablation of hepatic tumors
Radiofrequency (RF) ablation is an image-guided minimally invasive therapy which destroys a tumor by locally inducing electrical energy into the malignant tissue through a radiofrequency applicator. Treatment success is essentially dependent on the accurate placement of the RF applicator. In the case of CT-guided RF ablation of liver tumors, a central problem during monitoring is the reduced quality and information content in the peri-interventional images compared to the images used for planning. Therefore, the question of how to effectively transfer information from the planning scan into the peri-interventional scan in order to support the interventionalist is of high interest. Key to such an enhancement of peri-interventional scans is an adequate registration of the pre- and peri-interventional image, which also needs to be fast since intervention duration is still a challenge. We present an approach for the fast and automatic registration of a high quality CT volume scan of the liver to a spiral CT scan of lower quality. Our method combines an approximate pre-registration to compensate large displacements and a rigid registration of a liver subvolume for further refinement. The method focuses on the position of the tumor to be ablated and the corresponding access path. Thereby, it achieves both fast and precise results in the region of interest. A preliminary evaluation, on 37 data sets from 20 different patients, shows that the registration is performed within a maximum of 18 seconds, while obtaining high accuracy in the relevant region of the liver comprising tumor and the planned access path.
- 23 November 2007
- Published by Springer Nature in Der Radiologe
- Vol. 47 (12) , 1072-1082
Interventionelle Kombinationstherapien
- 23 November 2007
- Published by Springer Nature in Der Radiologe
- Vol. 47 (12) , 1072-1082
Interventionelle Kombinationstherapien
- 1 September 2007
- Published by Elsevier in Journal de Radiologie
- Vol. 88 (9) , 1230-1237
La résonance magnétique interventionnelle en pathologie ostéoarticulaire
- 1 September 2007
- Published by Elsevier in Journal de Radiologie
- Vol. 88 (9) , 1230-1237
La résonance magnétique interventionnelle en pathologie ostéoarticulaire
- 15 February 2007
- Published by Springer Nature in European Radiology
- Vol. 17 (8) , 2062-2070
Actual role of radiofrequency ablation of liver metastases
The liver is, second only to lymph nodes, the most common site for metastatic disease irrespective of the primary tumour. More than 50% of all patients with malignant diseases will develop liver metastases with a significant morbidity and mortality. Although the surgical resection leads to an improved survival in patients with colorectal metastases, only approximately 20% of patients are eligible for surgery. Thermal ablation and especially radiofrequency ablation emerge as an important additional therapy modality for the treatment of liver metastases. RF ablation shows a benefit in life expectancy and may lead in a selected patient group to cure. Percutaneous RF ablation appears safer (versus cryotherapy), easier (versus laser), and more effective (versus ethanol instillation and transarterial chemoembolisation) compared with other minimally invasive procedures. RF ablation can be performed by a percutaneous, laparoscopical or laparotomic approach, and may be potentially combined with chemotherapy and surgery. At present ideal candidates have tumours with a maximum diameter less than 3.5 cm. An untreatable primary tumour or a systemic disease represents contraindications for performing local therapies. Permanent technical improvements of thermal ablation devices and a better integration of thermal ablation in the overall patient care may lead to prognosis improvement in patients with liver metastases.
- 15 February 2007
- Published by Springer Nature in European Radiology
- Vol. 17 (8) , 2062-2070
Actual role of radiofrequency ablation of liver metastases
The liver is, second only to lymph nodes, the most common site for metastatic disease irrespective of the primary tumour. More than 50% of all patients with malignant diseases will develop liver metastases with a significant morbidity and mortality. Although the surgical resection leads to an improved survival in patients with colorectal metastases, only approximately 20% of patients are eligible for surgery. Thermal ablation and especially radiofrequency ablation emerge as an important additional therapy modality for the treatment of liver metastases. RF ablation shows a benefit in life expectancy and may lead in a selected patient group to cure. Percutaneous RF ablation appears safer (versus cryotherapy), easier (versus laser), and more effective (versus ethanol instillation and transarterial chemoembolisation) compared with other minimally invasive procedures. RF ablation can be performed by a percutaneous, laparoscopical or laparotomic approach, and may be potentially combined with chemotherapy and surgery. At present ideal candidates have tumours with a maximum diameter less than 3.5 cm. An untreatable primary tumour or a systemic disease represents contraindications for performing local therapies. Permanent technical improvements of thermal ablation devices and a better integration of thermal ablation in the overall patient care may lead to prognosis improvement in patients with liver metastases.
- 1 December 2006
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 241 (3) , 746-752
MR-guided Radiofrequency Ablation: Do Magnetic Fields Influence Extent of Coagulation in ex Vivo Bovine Livers?
Purpose: To prospectively determine if static magnetic fields of magnetic resonance (MR) imagers affect radiofrequency (RF) ablation coagulation volume and shape. Materials and Methods: Ex vivo RF ablations of bovine livers were performed with magnetic field strengths of 0.2, 1.5, and 3.0 T and were compared with ablations performed outside the magnetic field in a control group. Two MR-compatible monopolar RF devices (internally cooled single and cluster electrodes) were systematically tested. Length of long axis (y-axis), length of two short axes (x- and z-axes), and coagulation volume and shape measured outside and inside different magnetic fields were compared with the Dunnett test. Significance level was set to .05. Results: For the single electrode, no significant difference was observed between length of short axes and coagulation volume and shape measured inside and outside the magnetic field. Mean x- and z-axis lengths were 2.3 and 2.6 cm, respectively, outside the magnetic field; 2.4 and 2.4 cm, ...
- 1 December 2006
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 241 (3) , 746-752
MR-guided Radiofrequency Ablation: Do Magnetic Fields Influence Extent of Coagulation in ex Vivo Bovine Livers?
Purpose: To prospectively determine if static magnetic fields of magnetic resonance (MR) imagers affect radiofrequency (RF) ablation coagulation volume and shape. Materials and Methods: Ex vivo RF ablations of bovine livers were performed with magnetic field strengths of 0.2, 1.5, and 3.0 T and were compared with ablations performed outside the magnetic field in a control group. Two MR-compatible monopolar RF devices (internally cooled single and cluster electrodes) were systematically tested. Length of long axis (y-axis), length of two short axes (x- and z-axes), and coagulation volume and shape measured outside and inside different magnetic fields were compared with the Dunnett test. Significance level was set to .05. Results: For the single electrode, no significant difference was observed between length of short axes and coagulation volume and shape measured inside and outside the magnetic field. Mean x- and z-axis lengths were 2.3 and 2.6 cm, respectively, outside the magnetic field; 2.4 and 2.4 cm, ...
- 5 October 2006
- Published by Springer Nature in European Radiology
- Vol. 17 (3) , 725-733
Image-guided radiofrequency ablation of renal cell carcinoma
The incidence of renal cell carcinoma is rising with the increased number of incidental detection of small tumours. During the past few years, percutaneous imaging-guided radiofrequency ablation has evolved as a minimally invasive treatment of small unresectable renal tumours offering reduced patient morbidity and overall health care costs. In radiofrequency ablation, thermal energy is deposited into a targeted tumour by means of a radiofrequency applicator. In recent studies, radiofrequency ablation was shown to be an effective and safe modality for local destruction of renal cell carcinoma. Radiofrequency applicator navigation can be performed via ultrasound, computed tomography or magnetic resonance guidance; however, ultrasound seems less favourable because of the absence of monitoring capabilities during ablation. On-line monitoring of treatment outcome can only be performed with magnetic resonance imaging giving the possibility of eventual applicator repositioning to ablate visible residual tumour tissue. Long-term follow-up is crucial to assess completeness of tumour ablation. New developments in ablation technology and radiological equipment will further increase the indication field for radiofrequency ablation of renal cell carcinoma. Altogether, radiofrequency ablation seems to be a promising new modality for the minimally invasive treatment of renal cell carcinoma, which was demonstrated to exhibit high short-term effectiveness.
- 5 October 2006
- Published by Springer Nature in European Radiology
- Vol. 17 (3) , 725-733
Image-guided radiofrequency ablation of renal cell carcinoma
The incidence of renal cell carcinoma is rising with the increased number of incidental detection of small tumours. During the past few years, percutaneous imaging-guided radiofrequency ablation has evolved as a minimally invasive treatment of small unresectable renal tumours offering reduced patient morbidity and overall health care costs. In radiofrequency ablation, thermal energy is deposited into a targeted tumour by means of a radiofrequency applicator. In recent studies, radiofrequency ablation was shown to be an effective and safe modality for local destruction of renal cell carcinoma. Radiofrequency applicator navigation can be performed via ultrasound, computed tomography or magnetic resonance guidance; however, ultrasound seems less favourable because of the absence of monitoring capabilities during ablation. On-line monitoring of treatment outcome can only be performed with magnetic resonance imaging giving the possibility of eventual applicator repositioning to ablate visible residual tumour tissue. Long-term follow-up is crucial to assess completeness of tumour ablation. New developments in ablation technology and radiological equipment will further increase the indication field for radiofrequency ablation of renal cell carcinoma. Altogether, radiofrequency ablation seems to be a promising new modality for the minimally invasive treatment of renal cell carcinoma, which was demonstrated to exhibit high short-term effectiveness.
- 1 August 2006
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 187 (2) , 571-574
Percutaneous MR-Guided Radiofrequency Ablation of Recurrent Sacrococcygeal Chordomas
OBJECTIVE. Radiofrequency ablation is emerging as a therapeutic technique for the treatment of an increasing variety of tumors. Exact visual guidance to the tumor and controlled delivery of energy is pivotal for ablation success.CONCLUSION. Introducing MRI as a guidance technique ideally uses tumor-specific tissue characteristics, allows direct multiplanar reconstruction for precise needle positioning, and permits real-time monitoring and assessment of treatment-induced tissue signal changes to increase the safety of the procedure.
- 1 August 2006
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 187 (2) , 571-574
Percutaneous MR-Guided Radiofrequency Ablation of Recurrent Sacrococcygeal Chordomas
OBJECTIVE. Radiofrequency ablation is emerging as a therapeutic technique for the treatment of an increasing variety of tumors. Exact visual guidance to the tumor and controlled delivery of energy is pivotal for ablation success.CONCLUSION. Introducing MRI as a guidance technique ideally uses tumor-specific tissue characteristics, allows direct multiplanar reconstruction for precise needle positioning, and permits real-time monitoring and assessment of treatment-induced tissue signal changes to increase the safety of the procedure.
- 1 June 2005
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (16) , 3716
Phase II study of a combination of radiofrequency ablation (RFA) and systemic chemotherapy for patients with colorectal liver metastases
3716 Background: More than 25% of patients (pts) with colorectal cancer (CRC) develop metastases confined to the liver (LM) without extra hepatic spread. In these pts surgery is the mainstay of treatment; however, not all pts are suitable for a surgical approach. This study has investigated the toxicity and efficacy of percutaneous RFA in combination with FOLFOX-4 chemotherapy in pts with inoperable LM of CRC. Methods: Pts with a maximum of 5 non-resectable LM up to a maximal size < 5 cm without extra hepatic spread were allocated to 12 cycles of systemic chemotherapy with FOLFOX-4 (every 2 wks: oxaliplatin 85 mg/sqm IV, D 1; folinic acid 200 mg/sqm IV over 2h and 5-FU 400 mg/sqm IV bolus followed by 600 mg/sqm IV 22h-infusion, D 1 and 2). Percutaneous RFA with internally cooled electrodes (Cool Tip, Valleylab, Boulder, Co) controlled by simultaneous CT or MRI guidance was performed after completion of 4 cycles and repeated if required. Follow-up investigations including dynamic MRI have been done after every 4 cycles of FOLFOX-4, and every three month after stop of treatment. Results: Thirteen pts have prospectively entered the study. Pts’ characteristics: m/f 9/4; median age 63 yrs (range, 44 - 78); primary tumor colon 9, rectum 4. Five pts were diagnosed with synchronous and 7 pts with metachronous LM with a median interval of 8 mos. AJCC classification at initial diagnosis: stage II/III/IV 4/4/5. Median no. of LM: 3 (range, 1 - 5), size range 7 - 48 mm. The median follow-up was 14.5 mos (range, 2 - 36). WHO Grade 4 leucocytopenia occurred in 1 pt; Grade 3 toxicity: diarrhoea 2 pts, infection 2 pts, peripheral NP 1 pt, pain 1 pt. Of the 12 pts, who have completed the protocol 8 pts achieved a complete remission (CR) lasting 9.5 mos (range, 2 - 32). 2 pts attained a partial remission and 1 pt had intrahepatic progressive disease. Conclusions: In a well defined subgroup of pts with LM of CRC origin the combination of RFA and systemic chemotherapy is a feasible approach with a low toxicity and complication rate. This combination therapy can achieve complete responses without an operative approach. Median duration of remissions warrants further investigation of a combined treatment approach in controlled clinical trials. No significant financial relationships to disclose.
- 1 June 2005
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (16) , 3716
Phase II study of a combination of radiofrequency ablation (RFA) and systemic chemotherapy for patients with colorectal liver metastases
3716 Background: More than 25% of patients (pts) with colorectal cancer (CRC) develop metastases confined to the liver (LM) without extra hepatic spread. In these pts surgery is the mainstay of treatment; however, not all pts are suitable for a surgical approach. This study has investigated the toxicity and efficacy of percutaneous RFA in combination with FOLFOX-4 chemotherapy in pts with inoperable LM of CRC. Methods: Pts with a maximum of 5 non-resectable LM up to a maximal size < 5 cm without extra hepatic spread were allocated to 12 cycles of systemic chemotherapy with FOLFOX-4 (every 2 wks: oxaliplatin 85 mg/sqm IV, D 1; folinic acid 200 mg/sqm IV over 2h and 5-FU 400 mg/sqm IV bolus followed by 600 mg/sqm IV 22h-infusion, D 1 and 2). Percutaneous RFA with internally cooled electrodes (Cool Tip, Valleylab, Boulder, Co) controlled by simultaneous CT or MRI guidance was performed after completion of 4 cycles and repeated if required. Follow-up investigations including dynamic MRI have been done after every 4 cycles of FOLFOX-4, and every three month after stop of treatment. Results: Thirteen pts have prospectively entered the study. Pts’ characteristics: m/f 9/4; median age 63 yrs (range, 44 - 78); primary tumor colon 9, rectum 4. Five pts were diagnosed with synchronous and 7 pts with metachronous LM with a median interval of 8 mos. AJCC classification at initial diagnosis: stage II/III/IV 4/4/5. Median no. of LM: 3 (range, 1 - 5), size range 7 - 48 mm. The median follow-up was 14.5 mos (range, 2 - 36). WHO Grade 4 leucocytopenia occurred in 1 pt; Grade 3 toxicity: diarrhoea 2 pts, infection 2 pts, peripheral NP 1 pt, pain 1 pt. Of the 12 pts, who have completed the protocol 8 pts achieved a complete remission (CR) lasting 9.5 mos (range, 2 - 32). 2 pts attained a partial remission and 1 pt had intrahepatic progressive disease. Conclusions: In a well defined subgroup of pts with LM of CRC origin the combination of RFA and systemic chemotherapy is a feasible approach with a low toxicity and complication rate. This combination therapy can achieve complete responses without an operative approach. Median duration of remissions warrants further investigation of a combined treatment approach in controlled clinical trials. No significant financial relationships to disclose.
- 1 August 2004
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 86 (8) , 1761-1766
Preoperative Marking of Musculoskeletal Tumors Guided by Magnetic Resonance Imaging
Background: The purpose of this study was to evaluate a new stereotactic method for preoperative coil-marking of musculoskeletal tumors with use of interventional magnetic resonance imaging.
- 1 August 2004
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 86 (8) , 1761-1766
Preoperative Marking of Musculoskeletal Tumors Guided by Magnetic Resonance Imaging
Background: The purpose of this study was to evaluate a new stereotactic method for preoperative coil-marking of musculoskeletal tumors with use of interventional magnetic resonance imaging.